Fundamentals for Ecolab Inc.
ECL's low earnings and revenue growth point to a potential decline in profits. This signals a downturn in financial performance, suggesting that the company might face chal...
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Revenue projections:
Financial Ratios:
| currentRatio | 1.113000 |
|---|---|
| forwardPE | 32.364834 |
| debtToEquity | 133.334000 |
| earningsGrowth | -0.049000 |
| revenueGrowth | 0.127000 |
| grossMargins | 0.440430 |
| operatingMargins | 0.184650 |
| trailingEps | 7.350000 |
| forwardEps | 9.405580 |
ECL's current ratio of 1.113 indicates strong liquidity, meaning the company can comfortably meet its short-term debt obligations. This financial position reflects ECL's ability to use its cash reserves and current assets to cover liabilities without facing any cash flow issues.
ECL's elevated debt-to-equity ratio highlights its heavy reliance on debt. This high leverage increases the company's exposure to financial risk, making it more vulnerable to market fluctuations and economic downturns.
ECL's low earnings and revenue growth point to a potential decline in profits. This signals a downturn in financial performance, suggesting that the company might face challenges in maintaining its current level of profitability.
ECL's negative gross and operating margins point to losses in both production and operations. This suggests the company is facing financial challenges and may need to address cost management or improve revenue generation.
Ecolab Inc.'s forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for Ecolab Inc.'s financial growth.
Price projections:
Insider Transactions:
ECL experienced 12 selling transactions, with market price of 285.23308817545575.ECL stock was bought in 6 transactions, while the market price was at 259.85999552408856.ECL's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.
Recommendation changes over time:
With analysts showing a buy bias for ECL, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning ECL as a safe and profitable place for investors to allocate their funds and seek growth.